UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 18, 2017 4:00 P.M.
Form:
S-3
CIK:
0001016169
Company Name:
ANTARES PHARMA, INC.
File Number:
333-217808